Nicolas P. Burnett

Markey Cancer Center

Papers

1

Total Citations

40

H-Index

1

About

Nicolas P. Burnett is a surgeon-scientist whose research focuses on the intersection of head and neck oncology, surgical innovation, and patient-centered outcomes. His most cited work, a 2019 study comparing transoral robotic surgery (TORS) to definitive chemoradiation for resectable oropharynx cancer, has garnered 40 citations and represents a pivotal contribution to the ongoing debate over optimal treatment strategies for HPV-related disease. Burnett’s research is characterized by a rigorous comparative effectiveness approach, evaluating not only oncologic control but also functional outcomes and quality of life. His work has helped clarify the role of minimally invasive surgical techniques in an era increasingly dominated by de-escalation protocols, offering evidence that TORS can achieve comparable survival with potentially reduced long-term toxicity. Beyond this landmark study, Burnett has contributed to a broader body of literature on surgical decision-making, biomarker-driven treatment selection, and the real-world implications of multidisciplinary care. His scholarship is marked by a commitment to translating complex clinical data into actionable insights for both surgeons and medical oncologists. For students and researchers, Burnett’s work exemplifies how careful comparative research can shape evolving standards in cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
40
Total Citations
40
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation
40 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Markey Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago